Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Parliamentary Panel Not Yet Ready To Recommend India’s CDA Bill

This article was originally published in PharmAsia News

Executive Summary

NEW DELHI - A parliamentary committee examining the bills to set up a central drug authority in India is not yet set to give its recommendations, which would pave the way for the bills to be debated and passed in the parliament. The CDA bill has been approved by the country's Cabinet of Ministers and is currently with the parliamentary panel

You may also be interested in...



India’s Central Drug Authority May Be Shelved; Four Zonal Authorities Mooted

Disseminated power appears to be the goal, but would the system require four times the paperwork?

India’s Central Drug Authority May Be Shelved; Four Zonal Authorities Mooted

Disseminated power appears to be the goal, but would the system require four times the paperwork?

India’s Central Drug Authority May Be Shelved; Four Zonal Authorities Mooted

MUMBAI - Efforts to streamline India's drug regulatory system into a single central authority may suffer a body blow as the parliamentary committee set up to study the proposed changes may recommend scrapping the new body. Top industry sources told PharmAsia News that the committee is not completely convinced about the advantages of having a Central Drug Authority

UsernamePublicRestriction

Register

OM006665

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel